Promoting Health Equity in Stroke: Transforming Patient Insights Into Change
CE Information
1.0 contact hourCompletion Time
1 hourAvailable Until
December 14, 2024Posted By
Prime CENavigate
Overview
Specialties
AdultSubspecialties
Cardiovascular, Neurology, and Primary CareIntended Audience: Physicians, PAs, NPs, nurses, pharmacists, nurse navigators, case managers, and social workers
Despite increased risk factors for stroke, under-represented racial and ethnic populations continue to experience inequities in stroke treatment and post-acute care. Join us for an expert-led discussion of strategies to promote health equity in stroke care including:
- Real-world insights and perspectives on health equity from stroke patients and providers
- Racial and socioeconomic factors that contribute to disparities in access to quality care and treatments
- Evidence-based strategies, tools, and resources to identify and resolve gaps in health equity in both acute and long-term stroke care
Learning Objectives
- Assess racial, ethnic, and socioeconomic factors, practice patterns, and barriers that challenge evidence-based, equitable, and personalized care for patients experiencing stroke
- Apply interprofessional strategies, resources, and shared decision-making to support personalized treatment and equitable access to stroke follow-up care
- Implement clinical practices based on the latest evidence on safety, efficacy, and time to treatment to support safe, effective, and quality care for individuals experiencing acute ischemic stroke
Speakers
Professor of Neurology and Associate Dean
UCSF School of Medicine
University of California, San Francisco
Chief of Staff, San Francisco VA Health Care System
San Francisco, CA
University of Miami Hospital
Department of Neurology
Miami, FL
CE Information
This activity offers 1.0 contact hour to attendees.
PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 1.0 contact hour (which includes 0 hour of pharmacology).
Disclosures
*PRIME® has identified, reviewed, and mitigated all relevant financial relationships that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity.
The following individuals have identified relevant financial relationships with ineligible companies to disclose:
-
Bruce I Ovbiagele, MD, MSc, MAS, MBA, MLS, FAAN (Course Director, Speaker)
Advisory Board or Panel – JanssenThe relationships reported above are related to the following therapeutic area: Neurology -
Negar Asdaghi, MD (Speaker)
Salary or Employment – American Heart Association, Florida Stroke RegistryThe relationships reported above are related to the following therapeutic area: Neurology -
M. Carter Denny, MD, MPH (Reviewer)
Speakers Bureau or other Promotional Education – AbbottThe relationships reported above are related to the following therapeutic area: Neurology
The following individuals have no relevant financial relationships with ineligible companies to disclose:
- Donna M Chiefari, BSc (Pharm), PharmD, RPh, FASHP (Reviewer)
- Ayrin L Hnosko PhD, LCSW (Planner)
- Joyce M Knestrick, PhD, CRNP, FAANP (Planner)
All PRIME® staff participating in planning and content development have no relevant financial relationships with ineligible companies to disclose.
Ready to start this activity?
Login required. You will be redirected to an external website to register for and complete this activity.
Log in and start activity